I feel deeply honored to receive the 2025 Dr. Josef Steiner Cancer Research Award for our work on decoding and rewiring the immune-evasive TME. It truly is a recognition of the entire team past and present as well as our collaborators and mentors.🙌 Thank you for your trust!

🔥Trio Fatale: Neutrophils, NETs and Necrosis 👉 authors.elsevier.com/a/1lk-k3qNrU... We summarized for @cp-immunity.bsky.social "Neutrophils drive vascular occlusion, tumour necrosis and metastasis" published in @nature.com by @megeblad.bsky.social @adrover.bsky.social rdcu.be/eFdau Congrats!

Excited to be in Paris this week for a joint seminar at @institutcurie.bsky.social and @institutpasteur.bsky.social . Looking forward to connecting with colleagues—and to showing my 👧 the city!

Exciting FULL PROFESSORSHIP at the Vienna BioCenter - Molecular Mechanisms of Disease Mechanisms: www.maxperutzlabs.ac.at/news/open-po... Come be our colleague!

Anyone working in metastasis research – the BEUG Foundation has once again opened the call for their Metastasis Research Prize. This prize is a wonderful recognition of innovative contributions and supports excellence in metastasis research across Europe. www.beugstiftung-metastase.de/apply-now/

As an academic editor: THANK YOU to anyone who declines a review but suggests alternative reviewers. Those suggestions are often spot on — especially junior scientists with the right expertise who give outstanding, detailed reviews. So helpful!

Inspirational indeed! Congratulations @marvintanenbaum.bsky.social and my dear friend @leilaakkari.bsky.social.

Big congratulations to Karin on this well-deserved recognition! @nkinl.bsky.social

Big congratulations to all the newly elected @embo.org Members! A special shoutout to @impvienna.bsky.social #ClemensPlaschka for this well-deserved recognition. Your contributions to life sciences continue to inspire and I count myself lucky to work with you!

🇦🇹 Scientists in Austria: Don’t miss this chance to hear directly from @embo.org Director Fiona Watt about funding opportunities available. A great way to learn and connect with the community! @vbcscitraining.bsky.social @impvienna.bsky.social

⭐ Faculty for the Future Fellows ⭐ Interesting opportunity for women scientists from the world’s developing and emerging economies schlumbergerfoundation.com/eligibility-...

Are you looking for a postdoc position? Interesting opportunity with Kristian Pietras in Lund working with a PhD student on our Marie Curie ADAPTMET ITN project www.nature.com/naturecareer...

🎉 Huge congratulations to our incredible scholarship recipients at the Cancer Immunotherapy/Immune Cell Therapies joint meeting! We hope your time in Banff was as inspiring and productive as you are. 🌟https://keysym.us/scholarshipssms. #KSCancerImmune25 #KSCellTherapy25 @obenaufa.bsky.social

So excited about @georgwinter.bsky.social being appointed as the new life science director of the Research Institute for Biomedical Artificial Intelligence, established with generous funding/support from @boehringerglobal.bsky.social and OeAW. A truly fantastic choice! Welcome to the VBC Georg!

So proud of you @aelewaut.bsky.social and big thank you to the ADF and @abbvie.bsky.social. This 💶 will help ease the start in the US #postdoc #newadventures

🎉Congratulations to @aelewaut.bsky.social, recent PhD graduate from the @obenaufa.bsky.social’s lab, who won the Egon Macher Award for her research on how cancer evades the immune system! Read more: www.imp.ac.at/news/article... @viennabiocenter.bsky.social

Excited to be back at my home turf. Big thanks for inviting me to the 2025 DocDay at the MedUni Graz. It’s been a while since I attended the 1st Doc Day #blastfromthepast

Miriam Molina Arcas from the Downward lab is presenting their exciting work on how to engage the immune system in KRAS driven tumors @molinaarcas.bsky.social @juliandownward.bsky.social important concepts close to my ❤️

Piro Lito @mskcancercenter.bsky.social kicking off the #EACRBI_MAPK25 conference 🤩

Starting now! EACR-Boehringer Ingelheim Conference on Drugging and Regulating the MAP Kinase Pathway @helloeacr.bsky.social @boehringerglobal.bsky.social Looking forward to two days of exciting science and engaging discussions!

🎉 Today, we gathered online for the #AdaptMet Kick-Off Meeting! A fantastic start to this journey, bringing together top researchers & partners to train the next generation of metastasis experts. Exciting discussions & collaborations ahead—stay tuned! 🔬✨ #CancerResearch

At the IMP we’re dedicated to the fun of finding out. Few places in the world let you dive into curiosity-driven science like we do. 📽️Watch what the IMP is all about: youtu.be/mtl5Vod652Q @viennabiocenter.bsky.social

Happy New Year! I am a newly-arrived refugee from the other platform. Looking forward to (re-)connecting with friends and colleagues in this community!

🌟Keystone Cancer Immunotherapy conference 2025 🌟 Speaker Highlight #2 at #KSCancerImmune25: Dr. Ton N. Schumacher @nkinl.bsky.social will discuss how T cells detect tumors in “Dissecting T Cell Recognition of Cancer.” Don’t miss his cutting-edge immunology insights!

🌟Keystone Cancer Immunotherapy conference 2025 🌟 #KSCancerImmune25 Speaker Highlight #1 Dr. Carl June, the father of CAR T-cell therapy and 2024 #BreakthroughPrize winner will share critical advances in cancer immunology in his talk “Cell Therapies: Current State of the Art”.

The new CRISPR-StAR tool by @ulielling.bsky.social and team provides elegant new opportunities for in vivo screens. Glad we @aelewaut.bsky.social could contribute a bit.

Congratulations on this body of work! What a great start into 2025 for the @mafdawson.bsky.social lab!

Looking for an enthusiastic bioinformatician (long-term postdoctoral follow or staff scientist) interested in cancer/melanoma biology and therapy resistance. Data Science (single-cell, spatial multiomics integration), Machine learning, R, Pyhthon... jobso.id/ik9e

Exciting paper by Chris Vakoc @cshlaboratory.bsky.social on how to target the YAP/TAZ pathway out in Cancer Discovery! aacrjournals.org/cancerdiscov...

Thrilled to share that our paper www.nature.com/articles/s41... is featured in a fantastic Nature News & Views piece by thomastueting.bsky.social! 🎉 Grateful for the spotlight on our research and its impact on understanding cancer immunology. www.nature.com/articles/d41... 👀👉 rdcu.be/d3cRz

The kids are absolutely loving Prof. Bombasti at our annual Holiday Party! 😍 It’s such a joy to see them return year after year and watch them grow. @impvienna.bsky.social @vbcscitraining.bsky.social @viennabiocenter.bsky.social #WorkLifeIntegration

Come join us and @svanharanta.bsky.social @cedric-blanpain.bsky.social Roger Gomis @irbbarcelona.bsky.social @obenaufa.bsky.social Karin de Visser @nkinl.bsky.social @grauperalab.bsky.social @prat-aleix-md.bsky.social @vickysanzmoreno.bsky.social @johannajoyce.bsky.social @momobentires.bsky.social

The December issue of Cancer Discovery is now online! The cover features work by Christopher Vakoc and colleagues (@cshlnews.bsky.social) showing that MARK2/MARK3 kinases are catalytic codependencies of YAP/TAZ in human cancer. Find it here: aacrjournals.org/cancerdiscov...

Another interesting approach to improve T cell mediated immunity by the Elledge lab!

Congratulations to the #ERCCog recipients! 🎉 To everyone who applied but didn’t make it this time - keep pushing forward. We need more funds to support the brilliant ideas out there! tinyurl.com/ercog2024ls

Great to see this out @amandaanderssonr.bsky.social!

It’s hard to top Vienna as a conference location at this time of year! 🎄🌟 Many thanks to all the organizers of #EMDS2024 for this great meeting 🙏 and to all the presenters and participants for such a diversity of myeloid cell science and rich discussions 🧪 🤩

Thanks for the thread and congratulations for the wonderful work! Somehow the link to the paper didn't work for me, but I found it and here it is in case others have problems also www.nature.com/articles/s41...

Our Paper out in @natureportfolio.bsky.social with correct link www.nature.com/articles/s41...

Looking forward to celebrating with @johannajoyce.bsky.social and Karin de Visser at the Vienna Christmas market! #myeloidcells rule!

#Immunotherapy has transformed #cancer treatment, but some cancers evade immune defenses, causing resistance. @obenaufa.bsky.social's lab has discovered how inflammatory monocytes—a type of immune cell—can reactivate cancer-killing T cells within tumors. Read more: imp.ac.at/news/article...

Thanks for the shoutout @lozanzi.bsky.social!

1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...

Yeah so exciting! Plus trogocytosis 😍! Watch out for our upcoming tweetorial on our new paper with Jan coming out this afternoon 😊

You wanted starter packs to be searchable. Our engineers are busy keeping us online, so in the meantime, an independent developer built a new searchable library of starter packs. This is the beauty of building in the open 🦋

We are looking for a postdoc to work on #lncRNAs, #translational regulation and #Cancer. If you are passionate, curious and able to work independently please consider to to e-mail me to discuss this further.

Excited to present our brand new data (published tomorrow 🥳) at the #EMDS meeting in Vienna emds2024.com What a fantastic speaker line-up! Can't wait to take a deep dive into myeloid cell biology.

Hello Bluesky, we are recruiting PhD students in cancer and metastasis biology! This is a fantastic program that brings together several leading European research institutes. Details here: adaptmet.eu/recruitment/

Once again highlighting spatial co-localization cells between T cells and myeloid cells as critical determinants of therapy response.